US Patent Issued to GPN Vaccines on Feb. 24 for "Streptococcal vaccine formulations and uses thereof" (Australian Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,409, issued on Feb. 24, was assigned to GPN Vaccines Ltd (Yarralumla, Australia).

"Streptococcal vaccine formulations and uses thereof" was invented by Erin Bridget Brazel (Woodville West, Australia), Mohammed Alsharifi (Elizabeth Park, Australia), Shannon Christa David (Brompton, Australia), Timothy Raymond Hirst (Yarralumla, Australia) and James Cleland Paton (Parkside, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to streptococcal vaccine formulations and their use in generating immunity against streptococcal infection."

The patent was filed on May 21, 2021, under Application No. 17/327,513.

*For further...